1. Background {#sec1}
=============

Populations of black African (BA) ethnicity have a higher prevalence \[[@B1], [@B2]\] and earlier age of onset \[[@B3], [@B4]\] of type 2 diabetes (T2D) compared to those of white European (WE) ethnicity. While there is evidence that part of the disparity is due to environmental and cultural factors (such as socioeconomic status and diet) \[[@B5], [@B6]\], studies which adjust for these variables have found persistently higher rates of T2D and poorer glycaemic control in BA populations \[[@B7], [@B8]\], suggesting that ethnic-specific pathophysiological differences also play a role.

It has been hypothesised that in BA populations, beta cell function is upregulated or exaggerated in comparison to WE \[[@B9], [@B10]\], possibly mediated by lower adiponectin levels \[[@B11], [@B12]\], greater sensitivity of the beta cell to free fatty acid (FFA) stimulation \[[@B13], [@B14]\], or dietary factors such as an increased fat-to-carbohydrate ratio \[[@B15], [@B16]\]. This appears to be borne out by a meta-analysis of ethnic differences in insulin secretion by Kodama et al. \[[@B17]\], which concludes that BA exhibit a higher acute insulin response to glucose (AIRg, as measured by the intravenous glucose tolerance test) compared to WE. It has been speculated that this state of "upregulated" beta cell function plays a role in the increased risk of T2D in BA by predisposing to premature beta cell exhaustion \[[@B9]\].

There is no widely accepted "gold standard" method of assessing beta cell function *in vivo*. The most common techniques measure insulin response following the stimulation of the beta cell by glucose, either intravenously (as in the case of the hyperglycaemic clamp, graded glucose infusion, or intravenous tolerance test, which may be modified by intravenous insulin or tolbutamide) or orally (following the oral glucose tolerance test (OGTT) or the mixed meal tolerance test (MMTT)) \[[@B18]\]. Other techniques use intravenous arginine or glucagon to provoke a robust insulin secretory response \[[@B18]\]. Surrogate indices are also used, which may be derived from fasting glucose and insulin, such as the homeostatic model assessment of beta cell function (HOMA%B), or from the OGTT/MMTT, such as the insulinogenic index or the corrected insulin response (CIR) \[[@B18]\]. Each method has its strengths and limitations; for example, oral glucose and mixed meal tests are highly physiological while intravenous techniques allow specific assessment of the beta cell by excluding the modulating effect of the incretin hormones \[[@B18], [@B19]\].

There are two important factors to consider when assessing the evidence for "upregulated" beta cell function in BA. Firstly, "beta cell function" implies the concept of the beta cell adequately meeting its physiological role of maintaining glucose homeostasis; that is, it requires assessment of insulin secretion not in isolation but in the context of prevailing insulin sensitivity. Secondly, peripheral insulin levels are determined by both the rate of insulin secretion and the rate of hepatic insulin extraction (HIE), as insulin is secreted by the pancreatic beta cell into the portal vein and undergoes first pass metabolism in the liver before entering the systemic circulation \[[@B20]\]. As C-peptide is cosecreted with insulin into the portal vein in equimolar quantities and undergoes negligible hepatic extraction, measurements of plasma C-peptide are a better reflection of beta cell insulin secretion than plasma insulin levels \[[@B21]\].

The purpose of this systematic review is to examine the evidence for the impact of BA ethnicity on physiological differences in beta cell function in adulthood, taking into account both adjustments made for insulin sensitivity and the differentiation between beta cell insulin secretion and HIE. Unlike previous reviews, it examines adults only, as paediatric populations with impaired glucose regulation are likely to represent a more extreme phenotype. Furthermore, this review will include studies employing a variety of methodologies, in order to obtain a more comprehensive review of ethnic differences in beta cell function.

2. Methods and Procedures {#sec2}
=========================

2.1. Search Strategy {#sec2.1}
--------------------

The study was formulated with reference to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) \[[@B22]\].

A modified "PICO" (Population, Intervention, Comparison, Outcome) framework was used. As the relevant topic is ethnic difference rather than intervention, "Phenomenon of Interest" was substituted for "Intervention" and "Outcome."

Using this framework, the following question was generated: "how does beta cell function in adults of black African ethnicity differ from that of adults of white European ethnicity across all ranges of glucose tolerance?"

The Ovid Medline database was searched in June 2018 to identify potentially relevant publications. Keywords included "African", "Caribbean", "beta cell function", "acute insulin response (AIR)", "disposition index (DI)", "insulinogenic index", and "insulin secretion". The complete search string may be found in the appendix. No limits were set in terms of publication date or language.

Inclusion and exclusion criteria were predetermined in order to systematically select studies. Inclusion criteria Population: adults (over 18 years of age) of black African ethnicity. To include both indigenous populations and those of the diaspora, e.g., African Americans, African-Caribbean, and indigenous African. Both male and female. Across all ranges of glucose tolerance: normal glucose tolerant, impaired glucose tolerant, impaired fasting glucose, and type 2 diabeticPhenomenon of interest: beta cell function. Indices included were HOMA%B, insulin secretion, AIR (acute insulin response), EIR (early insulin response), insulinogenic index, corrected insulin response (CIR), disposition index (DI), beta cell responsivity to glucose (Phi1, Phi2, and Phi total), insulin secretion rate (ISR), and insulin secretory function (ISF)Comparison population: adults of white European ethnicity. To include whites, Caucasians, non-Hispanic whites, and white EuropeansExclusion criteria Population: population contains only subjects \< 18 yearsPhenomenon of interest: no assessment of beta cell function, e.g., only genetic data collected, only insulin clearance assessed, only fasting insulin/C-peptide without model assessmentComparison population: no direct *statistical* comparison to WE population (or data not reported in comparison to WE population)

Two investigators (ML and OH) independently screened the search results to determine study inclusion to minimise bias. In the first step, studies were eliminated if the abstract indicated that at least one criterion was not met. In the second step, full-text manuscripts were obtained from the remaining studies to assess them against the inclusion and exclusion criteria. The references of included studies were also reviewed to identify further suitable studies.

If data from the same study were reported in multiple publications, only the publication with the greatest number of participants in the analyses was included.

2.2. Quality Assessment {#sec2.2}
-----------------------

The Newcastle-Ottawa scale \[[@B23]\] (developed as a quality assessment tool for nonrandomised studies) was used to determine the quality and risk of bias of the selected papers. A modified version of the scale for cross-sectional studies (mNOS) was formulated (see the appendix).

In the absence of formal thresholds for rating quality, studies were judged to be at high risk of bias if they scored 5 stars or below on the mNOS and low risk of bias if they scored 6 stars or above.

3. Results {#sec3}
==========

The selection of the included studies is shown in [Figure 1](#fig1){ref-type="fig"}. A total of 182 articles were screened; after the study selection process, 41 studies met the prespecified eligibility criteria and were included in the qualitative synthesis.

The characteristics of the included studies are shown in [Table 1](#tab1){ref-type="table"}. The majority were studies of African American populations (*n* = 30), but other study populations included indigenous black African (*n* = 5) \[[@B24]--[@B28]\], immigrant black African (*n* = 2) \[[@B29], [@B30]\], UK African-Caribbean (*n* = 3) \[[@B31]--[@B33]\], and a mixture of the above (*n* = 1) \[[@B34]\]. The total number of subjects of BA ethnicity in the included studies was 4619. The smallest cohort of BA subjects was 7 \[[@B24]\] and the largest was 752 \[[@B35]\]. The majority of studies (*n* = 25) were in NGT or nondiabetic populations only; three studies were in prediabetic (IFG/IGT) populations only \[[@B35]--[@B37]\], and three studies were in populations with T2D only \[[@B30], [@B32], [@B38]\]. Ten studies were in a population known to be of mixed glucose tolerance \[[@B31], [@B39]--[@B47]\].

The studies comprised 17 all-female cohorts \[[@B25]--[@B28], [@B37], [@B41], [@B43], [@B48]--[@B56]\], 3 all-male cohorts \[[@B24], [@B29], [@B30]\], and 21 mixed-sex cohorts. Where sex of subject was reported by ethnicity, the majority in both BA (3350 of 4395, or 76%) and WE (6630 of 10900, or 61%) subjects were female. There was evidence of sex-specific differences in insulin secretion within the BA population, with females exhibiting a greater insulin response compared to males \[[@B33], [@B57]\].

A variety of methodologies were employed to assess beta cell function, with some studies employing multiple methods. These included models based on fasting parameters (*n* = 5) \[[@B32], [@B36], [@B37], [@B41], [@B58]\] and measurements using data from oral glucose and mixed meal stimulation tests (*n* = 21), such as poststimulation insulin and/or C-peptide concentrations \[[@B24], [@B25], [@B28], [@B31], [@B37], [@B38], [@B50]\], corrected insulin response (CIR) \[[@B35], [@B42]\], insulinogenic index \[[@B27], [@B36], [@B40], [@B44], [@B55]\], and insulin and/or C-peptide area under the curve (AUC) \[[@B26], [@B29], [@B30], [@B34], [@B42], [@B48], [@B59], [@B60]\]. Of the studies using intravenous stimulation (*n* = 27), some studies employed multiple methods within the same study, most commonly the insulin-modified IVGTT (*n* = 15) \[[@B27], [@B36]--[@B39], [@B43]--[@B45], [@B49], [@B51]--[@B54], [@B56], [@B58]\]. Studies also employed the nonmodified IVGTT (*n* = 6) \[[@B33], [@B46], [@B59]--[@B62]\], the tolbutamide-modified IVGTT (*n* = 4) \[[@B43], [@B44], [@B51], [@B63]\], the hyperglycaemic clamp (*n* = 4) \[[@B30], [@B47], [@B64], [@B65]\], and the arginine-stimulated response (*n* = 2) \[[@B47], [@B60]\]. One study \[[@B25]\] used combined tolbutamide and glucagon intravenous stimulation.

Nineteen studies reported measurements of insulin secretion corrected for insulin sensitivity, with adjustment by HOMA-IR \[[@B28], [@B40]\], *M* value from hyperinsulinaemic-euglycaemic clamp \[[@B59], [@B62]\], insulin sensitivity index (ISI) \[[@B38], [@B42], [@B43]\], or by calculation of the disposition index (AIR × Si) \[[@B27], [@B33], [@B36], [@B37], [@B44], [@B45], [@B47], [@B53], [@B54], [@B58], [@B60], [@B61]\]. According to the prespecified quality criteria, one study was at high risk of bias (*n* = 1) \[[@B24]\] while the remainder were at low risk of bias (*n* = 40).

As the study population sizes are very different, the cumulative *n* has been calculated and presented for Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}; however, due to the high degree of variability in study populations and methodologies, this is intended to be indicative rather than for direct quantitative comparison.

3.1. Overall Findings {#sec3.1}
---------------------

The majority---thirty-four out of forty-one studies---found evidence of a higher peripheral insulin response in people of BA compared to WE ethnicity.

### 3.1.1. Adjustment for Adiposity {#sec3.1.1}

Some studies (*n* = 14) controlled for measures of adiposity, whether using surrogate measurements such as waist circumference or waist-hip ratio \[[@B28], [@B38], [@B39], [@B41], [@B60]\], or using hydrostatic weighing \[[@B49]\] or DXA to assess percentage body fat \[[@B27], [@B36], [@B37], [@B42], [@B52], [@B55], [@B59]\], or using CT imaging to assess volume of visceral and subcutaneous fat deposits \[[@B54]\]. All 14 studies consistently demonstrated that hyperinsulinaemia of BA persisted after adjustment for adiposity.

### 3.1.2. Adjustment for Insulin Sensitivity {#sec3.1.2}

The relative hyperinsulinaemia of BA ethnicity persisted in the majority of studies which adjusted for the prevailing insulin sensitivity (*n* = 15), while a minority (*n* = 2) of studies found that hyperinsulinaemia was an appropriate compensatory response to higher insulin resistance \[[@B27], [@B33]\].

### 3.1.3. Models Based on Fasting Measures {#sec3.1.3}

Five studies calculated HOMA%B using fasting glucose and fasting insulin. Two studies, one in a nondiabetic and one in a mixed NGT/IFG population, found higher HOMA%B in BA \[[@B41], [@B58]\], one study in an IFG/IGT population found no significant ethnic difference \[[@B37]\], and two studies in IFG/IGT and type 2 diabetic populations found that HOMA%B was lower in BA compared to WE \[[@B32], [@B36]\].

### 3.1.4. Insulin Response Post Oral Glucose or Meal {#sec3.1.4}

Of the 21 studies reporting indices of insulin secretion based on oral glucose or meal tests ([Table 2](#tab2){ref-type="table"}), the majority found no ethnic difference in insulin response between BA and WE (*n* = 10).

Seven studies found a greater insulin response in BA \[[@B34], [@B35], [@B42], [@B44], [@B48], [@B50], [@B55]\] while two studies found a lower response \[[@B24], [@B25]\]. Two studies had different results in stratified cohorts, with a greater insulin response in BA in NGT subjects but no ethnic difference in IGT or T2D subjects \[[@B40]\] and a greater insulin response in BA in obese subjects but no ethnic difference in lean subjects \[[@B28]\].

Only three studies \[[@B26], [@B29], [@B30]\] employed the mixed meal test, while one study found a higher insulin levels at 30 mins post meal in BA \[[@B26]\]; none of these studies found significant ethnic differences in the incremental area under the curve for insulin post meal.

### 3.1.5. Insulin Response Post Intravenous Glucose {#sec3.1.5}

A consistent picture emerges from the 25 studies which assessed insulin response to intravenous glucose ([Table 2](#tab2){ref-type="table"}), with the overwhelming majority finding that the insulin response was greater in those of BA compared to WE ethnicity, across all categories of glucose tolerance (*n* = 23). One study in a T2D population found no ethnic difference \[[@B30]\], and one study in an NGT population found the response was lower in BA compared to WE \[[@B25]\].

### 3.1.6. Beta Cell Insulin Secretion Using C-Peptide Measurements {#sec3.1.6}

Fourteen out of forty-one studies used C-peptide measurements in their assessment of beta cell function (see [Table 3](#tab3){ref-type="table"}). Most used oral glucose stimulation techniques (*n* = 9), with a minority using intravenous techniques (*n* = 3) \[[@B52], [@B56], [@B63]\] or a combination of both oral and intravenous stimulation (*n* = 2) \[[@B25], [@B30]\]. In NGT cohorts, findings were conflicting, with some studies finding that beta cell insulin secretion was higher in BA vs. WE (*n* = 4) \[[@B28], [@B48], [@B52], [@B56]\] while others found it was lower (*n* = 2) \[[@B25], [@B50]\] or that there was no significant difference (*n* = 2) \[[@B28], [@B29], [@B34], [@B63]\]. In exclusively IGT or T2D cohorts, beta cell insulin secretion by C-peptide measurement was found to be consistently lower in BA compared to WE, albeit the number of studies was very small (*n* = 3, comprising a total of 170 BA subjects) \[[@B30], [@B36], [@B37]\]. In two populations of mixed glucose tolerance, no significant difference was found \[[@B31], [@B42]\].

4. Discussion {#sec4}
=============

4.1. Overall Findings {#sec4.1}
---------------------

This systematic review is aimed at examining the evidence for "upregulated" beta cell function in adults of black African ethnicity; in particular, it sought to account for prevailing insulin sensitivity and to differentiate between insulin secretion and hepatic insulin extraction.

Overall, the results show that adults of black African ethnicity---whether indigenous or of the diaspora---have a greater peripheral insulin response compared to those of white European ethnicity. Their relative hyperinsulinaemia does not appear to be accounted for either by differences in insulin sensitivity or differences in adiposity.

Hyperinsulinaemia in black African populations appears to be a highly conserved trait \[[@B34]\] which has been demonstrated in prepubertal children \[[@B66]\] and which may be driven by both genetic and epigenetic factors \[[@B67]\]. It has been hypothesised that a robust insulin response may have evolved in this population to promote tissue growth, which is in keeping with the observation that BA youths tend to be taller than their white counterparts \[[@B68]\] and that BA populations have increased bone density \[[@B69]--[@B71]\] and muscle mass \[[@B72], [@B73]\] compared to WE.

However, there are several areas where this systematic review has demonstrated limitations or inconsistencies in our established understanding. There appear to be four key areas of methodology which affect the outcomes of each study: the use of C-peptide measurements to assess insulin secretion; the use of oral or intravenous methods to stimulate beta cell response; the glucose tolerance status of the study population; and, possibly, the sex of the population.

4.2. Effect of C-Peptide Measurement {#sec4.2}
------------------------------------

Only 14 out of the 41 studies measured C-peptide responses and were therefore able to differentiate between insulin secretory function and hepatic insulin extraction. This is of great importance, given that the evidence suggests that HIE is significantly lower in black compared to white ethnic populations \[[@B56], [@B66]\]. While the majority of studies found peripheral hyperinsulinaemia in BA adults, the use of C-peptide levels as a measure of beta cell insulin secretion gave rise to highly variable findings. Although direct quantitative comparison is not possible due to the heterogeneity of populations and methods used, the cumulative *n* presented in [Table 3](#tab3){ref-type="table"} suggests that the weight of evidence based on C-peptide measurements does not support the finding of beta cell upregulation in BA adults. This is in contrast to the work in children and adolescents, which has found both increased beta cell insulin secretion and reduced HIE in BA \[[@B15], [@B74], [@B75]\]. Whether BA adults exhibit increased beta cell secretion or whether their hyperinsulinaemia is driven predominantly by reduced HIE remains an unresolved question.

The differences between the findings in children and adults may be due to an age-related decline in beta cell function \[[@B76], [@B77]\], with reduced HIE playing a relatively more dominant role in hyperinsulinaemia of BA adults. It is interesting that HIE appears to be an important physiological process underlying ethnic differences in glucose metabolism. It has been previously noted that HIE is the primary cause of hyperinsulinaemia in subjects with more severe glucose intolerance \[[@B78]\] and that it may be an important determinant of future T2D in BA \[[@B79]\]. While reduced HIE is traditionally understood to be associated with visceral adiposity and increased levels of hepatic fat \[[@B80], [@B81]\], in BA populations there is conversely evidence of lower intrahepatic lipid compared to WE \[[@B82]--[@B85]\]. Therefore, the mechanism of reduced HIE in BA is yet to be fully determined, but potential routes of investigation include the role of inflammatory and vascular mediators \[[@B86], [@B87]\].

4.3. Effect of IV versus Oral Methods of Beta Cell Stimulation {#sec4.3}
--------------------------------------------------------------

Where previous reviews have been drawn from mainly intravenous studies \[[@B9], [@B17]\], here the inclusion of multiple methodologies of beta cell function assessment gives a more complex picture. Studies examining the response to intravenous glucose administration provide highly consistent evidence for hyperinsulinaemia in BA, whereas studies using oral glucose or meal ingestion have much more variable findings. The discrepancy between intravenous and oral studies has been previously noted in the literature \[[@B9]\] and remains largely unexplained. Differences in the incretin response are one possible mechanism, but there are no consistent findings from the few studies which have investigated ethnic differences in the incretin pathway \[[@B42], [@B88]--[@B90]\].

These observations call into question whether the ethnic differences seen during intravenous studies are clinically relevant if they cannot be reliably demonstrated under physiological conditions. In particular, the small subset of studies using arguably the most physiological method of assessment, i.e., the mixed meal tolerance test, did not find any ethnic differences in insulin response. Further investigation is needed to determine the mechanisms which lead to the route of delivery and the magnitude of the glucose load provoking different insulin responses in BA adults.

4.4. Effect of Glucose Tolerance Status {#sec4.4}
---------------------------------------

It should be noted that not all studies measured glucose tolerance as part of their protocols; hence, while the population was defined as "healthy" or "nondiabetic" it is conceivable that participants with impaired glucose regulation were included in the sample. Furthermore, many studies were comprised of cohorts of mixed glucose tolerance. Therefore, an attempt to examine ethnic differences by glucose tolerance was limited by the small number of relevant studies.

While there were only three studies which assessed insulin secretory function by C-peptide measurements in IGT/IFG or T2D cohorts where glucose tolerance was strictly defined \[[@B30], [@B36], [@B37]\], all three of these indicated that BA adults with impaired glucose tolerance and T2D exhibit greater insulin secretory deficits compared to WE. Interestingly, this is in direct contrast to data from paediatric populations, which demonstrates elevated insulin secretory function in BA across all categories of glucose tolerance \[[@B10], [@B75], [@B91], [@B92]\].

It may be that impaired glucose regulation in the paediatric/youth population represents a more extreme or aggressive phenotype compared to adults. In youth, glucose intolerance is likely to be associated with severe obesity \[[@B93]\] which promotes beta cell hypersecretion of insulin, whereas age-related beta cell decline in BA adults may account for their relatively greater insulin secretory deficits as they progress to T2D. The findings of this review raise the question of whether the beta cells of BA adults are more vulnerable to dysfunction than their WE counterparts as obesity and insulin resistance prevail.

4.5. Effect of Gender {#sec4.5}
---------------------

Although sex-specific differences were not explored by the majority of the studies, two studies found evidence that BA females exhibit greater hyperinsulinaemia compared with BA males \[[@B33], [@B57]\]. Enhanced postprandial insulin secretion in females compared to males has also been demonstrated in other ethnic groups, including white Americans \[[@B94]\] and East Asians \[[@B95]\]. While there was a predominance of female subjects in both ethnic groups (61% of WE and 76% of BA subjects across all included studies), the relatively higher proportion of females in the BA cohorts may have led to an overestimation of ethnic differences.

5. Conclusions {#sec5}
==============

While BA have a hyperinsulinaemic response to glucose, reduced hepatic insulin extraction rather than differences in beta cell function may be the primary determinant of ethnic differences in diabetes pathophysiology in adulthood. The available literature is predominantly drawn from female, NGT/nondiabetic subjects, and there are relatively few studies which look at exclusively IFG/IGT or T2D populations or which take differences in HIE into account. Furthermore, with the exception of responses to intravenous glucose, the reported direction and magnitude of differences in insulin responses to glucose challenges are not consistent across all studies. The methodology employed---namely, whether intravenous or oral techniques are used, whether C-peptide levels are assessed, and/or whether the glucose tolerance status of the population is studied---appears to have a significant impact on the findings made. The mechanisms of hyperinsulinaemia in BA adults, and how these may relate to their increased risk of T2D, therefore remain unclear.

The cumulative evidence demonstrates that further work is needed to determine these mechanisms, using rigorous methodology to differentiate between insulin secretion and insulin clearance, adjusting for insulin sensitivity, using both oral and intravenous techniques and examining subjects according to strictly defined categories of glucose tolerance.

A. Search Strategy for Ovid Medline {#secA}
===================================

exp African Continental Ancestry Group/afr∗.mp.ghana∗.mp.nigeria∗.mp.caribbean.mp.beta cell function.mp.insulin secretion.mp.insulin clearance.mp.acute insulin response.mp.beta cell respons∗.mp.insulinogenic index.mp.exp European Continental Ancestry Group/white european.mp.non-hispanic white.mp.caucasian.mp.exp DIABETES MELLITUS/ or exp Adult/diab∗.mp.glucose toleran∗.mp.non-diab∗.mp.healthy.mp.1 or 2 or 3 or 4 or 56 or 7 or 8 or 9 or 10 or 1112 or 13 or 14 or 1516 or 17 or 18 or 19 or 2021 and 22 and 23 and 24

B. Newcastle-Ottawa Scale, Modified for Cross-Sectional Studies {#secB}
===============================================================

The most appropriate statements are selected. Studies can score a maximum of 10 stars.

B.1. *Selection: Maximum 5 Stars* {#secB.1}
---------------------------------

Representativeness of the sample Truly representative of the average in the target population (all subjects or random sampling)^∗^Somewhat representative of the average in the target population (nonrandom sampling)^∗^No description of the sampling strategySelected group of users Selection of individuals to exclude factors that will bias results (e.g., medications affecting glucose metabolism)^∗^No relevant/systematic selectionSample size Justified and satisfactory (power calculation included)^∗^Not justifiedDiagnosis Characterisation of the diagnosis of diabetes subtype^∗∗^Diabetes subtype is provided^∗^No information regarding diabetes subtype

B.2. *Comparability: Maximum 2 Stars* {#secB.2}
-------------------------------------

The subjects in different outcome groups are comparable, based on the study design or analysis. Confounding factors are controlled: The study controls for the most important factor (BMI)^∗∗^The study controls for any additional factor (e.g., age, sex, insulin sensitivity, and diet)^∗^

B.3. *Outcome: Maximum 3 Stars* {#secB.3}
-------------------------------

Ascertainment of the method Validated measurement method (interassay CV included)^∗∗^Nonvalidated measurement method, but the method is available or described^∗^No description of the measurement toolStatistical test The statistical test used to analyse the data is clearly described and appropriate, and the measurement of the association is presented (including SD/SE and the probability level (*p* value))^∗^The statistical test is not appropriate, not described, or incomplete

AIRg:

:   Acute insulin response to glucose

BA:

:   Black African(s)

CIR:

:   Corrected insulin response

DXA:

:   Dual-energy X-ray absorptiometry

DI:

:   Disposition index

HIE:

:   Hepatic insulin extraction

HOMA%B:

:   Homeostatic model assessment of beta cell function

HOMA-IR:

:   Homeostatic model assessment of insulin resistance

iAUC:

:   Incremental area under the curve

IFG:

:   Impaired fasting glucose

IGT:

:   Impaired glucose tolerance

IVGTT:

:   Intravenous glucose tolerance test

MMTT:

:   Mixed meal tolerance test

OGTT:

:   Oral glucose tolerance test

Si:

:   Insulin sensitivity index

T2D:

:   Type 2 diabetes

WBISI:

:   Whole-body insulin sensitivity index

WE:

:   White European(s).
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Summary of characteristics of the included studies: methods, population of interest, glucose tolerance status, findings, and mNOS.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                            Methods                                                                                                   Study design                               Population of interest                                          Comparison population          Findings                                                   mNOS                                                                                                                                                                                                                                                                                                                                                                                                                
  ------------------------------------------------ --------------------------------------------------------------------------------------------------------- ------------------------------------------ --------------------------------------------------------------- ------------------------------ ---------------------------------------------------------- ---------------------------- ----------------------------------------- ------------------------------------------------------------- ------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---
  Rubenstein et al. \[[@B24]\]                     OGTT                                                                                                      Cross-sectional                            Native black South African, no FHx of T2D                       7                              30 ± 6                                                     100/0                        NGT                                       White South African, no FHx of T2D                            8      Similar fasting insulin levels, but lower serum insulin in response to oral glucose and lower renal insulin clearance in BA compared to WE                                                                                                                              5

  Shires et al. \[[@B25]\]                         "Maximal beta cell stimulation"---75 g oral glucose followed by IV tolbutamide and glucagon stimulation   Cross-sectional                            Obese native black South African                                10                             39.4 ± 1.7                                                 0/100                        Nondiabetic                               Obese white South African                                     8      Serum insulin and C-peptide levels significantly lower in BA compared to WE 30 mins after oral glucose and 30 mins after tolbutamide and glucagon                                                                                                                       6

  Cruickshank et al. \[[@B31]\]                    OGTT                                                                                                      Cross-sectional                            UK Afro-Caribbean                                               106                            56.6 ± 6.0 (F), 57.0 ± 5.0 (M)                             50/50                        NGT, IGT, and T2D                         White European                                                101    No statistically significant difference between C-peptide and insulin concentrations post oral glucose; however, difference in profiles led investigators to suggest impaired hepatic processing of insulin in BA.                                                      6

  Osei et al. \[[@B48]\]                           OGTT                                                                                                      Case control                               African American (first-degree relatives of T2D and controls)   24 relatives and 8 controls\   32 ± 2 (relatives) and 27 ± 2 (controls)                   0/100                        NGT                                       White American (first-degree relatives of T2D and controls)   22     In both first-degree relatives and controls, iAUC insulin and C-peptide were significantly higher in BA compared to WE.                                                                                                                                                 9
                                                                                                                                                                                                                                                                        Total = 32                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  UK Prospective Diabetes Study Group \[[@B32]\]   Fasting glucose and insulin to derive HOMA%B                                                              Prospective cohort                         UK Afro-Caribbean                                               387                            51.6 ± 7.4 (M)\                                            57/43                        T2D                                       UK Caucasian                                                  4177   Lower HOMA%B in BA compared to WE, adjusted for age and BMI. BA had higher fasting plasma glucose and higher HbA1c vs. WE.                                                                                                                                              9
                                                                                                                                                                                                                                                                                                       50.2 ± 7.2 (F)                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Osei et al. \[[@B63]\]                           Tolbutamide-modified IVGTT                                                                                Cross-sectional                            African American                                                32                             ---                                                        0/100                        NGT                                       White American                                                30     Higher insulin levels in BA but similar C-peptide levels compared to WE                                                                                                                                                                                                 9

  Haffner et al. \[[@B39]\]                        Insulin-modified IVGTT                                                                                    Prospective cohort                         African American                                                187 NGT, 101 IGT\              54.2 ± 0.7                                                 43/57                        NGT and IGT                               Non-Hispanic white                                            229    Higher AIR in BA compared to WE when adjusted for age, sex, BMI, and WHR. Greater insulin resistance in BA by Si                                                                                                                                                        9
                                                                                                                                                                                                                                                                        Total = 288                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Haffner et al. \[[@B38]\]                        OGTT\                                                                                                     Prospective cohort                         African American (overweight and obese)                         153                            57.1 ± 0.7                                                 45/55                        T2D                                       Non-Hispanic white (overweight and obese)                     105    OGTT: no difference in fasting and 2 h insulin. AIR higher in BA. No ethnic difference in Si. Adjusted for age, sex, obesity and WHR, fasting glucose, and therapy                                                                                                      9
                                                   Insulin-modified IVGTT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Osei et al. \[[@B34]\]                           OGTT                                                                                                      Cross-sectional                            Native Ghanaian, US immigrant Ghanaian, and African American    50, 31, and 66\                34.1 ± 1.0, 37.2 ± 1.6, and 33.3 ± 0.9                     39/61                        NGT                                       White American                                                39     Higher peak and iAUC insulin in BA compared to WE, no difference in C-peptide. Basal and postprandial HIE (by C-peptide to insulin molar ratio) lower in BA                                                                                                             9
                                                                                                                                                                                                                                                                        Total = 147                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Chiu et al. \[[@B64]\]                           Hyperglycaemic clamp                                                                                      Cross-sectional                            African American                                                9                              26                                                         56/44                        NGT                                       White American                                                34     Higher second-phase insulin response in BA, no difference in the 1st phase. Lower insulin sensitivity index in BA                                                                                                                                                       7

  Melby et al. \[[@B49]\]                          Insulin-modified IVGTT                                                                                    Cross-sectional                            African American                                                9                              22.5 ± 0.7                                                 0/100                        NGT                                       White American                                                8      Age-matched ethnic groups. Higher AIR in BA and lower insulin sensitivity by Si in BA. Similar age, BMI, and percentage body fat between ethnicities                                                                                                                    9

  Chiu et al. \[[@B65]\]                           Hyperglycaemic clamp                                                                                      Cross-sectional                            African American                                                11                             25                                                         45/55                        NGT                                       White American                                                46     Higher 1st and 2nd phase insulin response in BA, lower insulin sensitivity index                                                                                                                                                                                        6

  Chen et al. \[[@B50]\]                           Glucose challenge test (insulin and C-peptide 1-hour post 50 g glucose load)                              Prospective cohort                         African American pregnant women                                 343                            20.6 ± 0.2                                                 0/100                        NGT                                       White American pregnant women                                 118    Insulin and insulin to glucose ratio higher, but C-peptide and C-peptide to insulin ratio lower, in BA vs. WE. Similar BMI in both ethnic groups                                                                                                                        8

  Jensen et al. \[[@B40]\]                         OGTT                                                                                                      Cohort                                     African American                                                55                             41.8 ± 1.9                                                 38/62                        NGT, IFG/IGT, and T2D                     White American                                                217    Insulinogenic index adjusted for insulin sensitivity ((*Δ*I30/*Δ*G30)/HOMA-IR) higher in NGT BA vs. WE. No difference in IFG/IGT and T2D                                                                                                                                7

  Punyadeera et al. \[[@B26]\]                     MMTT                                                                                                      Cross-sectional                            Native black South African (lean and obese)                     8 (lean) and 9 (obese)\        31.9 ± 3.0 (lean) and 42.5 ± 2.6 (obese)                   0/100                        NGT                                       White South African (lean and obese)                          17     Higher insulin levels at 30 mins post meal in obese BA compared to obese WE. No difference in total insulin area under the curve between ethnic groups                                                                                                                  8
                                                                                                                                                                                                                                                                        Total = 17                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Velasquez-Mieyer et al. \[[@B42]\]               3 h OGTT                                                                                                  Cross-sectional                            African American (severely obese)                               16                             36 ± 2                                                     Not available by ethnicity   NGT and IGT                               White American (severely obese)                               26     Insulin iAUC and CIR at 30 mins higher in BA vs. WE, no significant difference in iAUC C-peptide. Similar WBISI and fat mass by DXA between ethnic groups                                                                                                               8

  Stefan et al. \[[@B59]\]                         OGTT, MMTT, and IVGTT                                                                                     Cross-sectional                            African American                                                30                             31 ± 1                                                     66/33                        NGT                                       White American                                                30     No ethnic difference in AUC insulin post OGTT or MMTT. Higher AIR after IVGTT in BA, when adjusted for insulin sensitivity by M-Low (from 2-step hyperinsulinaemic-euglycaemic clamp). BA and WE matched for age, sex, BMI, WHR, and percentage body fat.               9

  Torrens et al. \[[@B41]\]                        Fasting glucose and insulin to derive HOMA%B                                                              Prospective cohort                         African American                                                746                            46 ± 2.7                                                   0/100                        Nondiabetic; included subjects with IFG   Non-Hispanic white                                            1359   HOMA%B higher in BA after controlling for alcohol consumption, waist circumference, triglycerides, and prevalence of IFG                                                                                                                                                8

  Albu et al. \[[@B43]\]                           Insulin- or tolbutamide-modified IVGTT                                                                    Cross-sectional                            African American                                                32                             36.8 ± 1.3                                                 0/100                        NGT and IGT                               White American                                                28     Higher AIR in BA, which persisted when adjusted for insulin sensitivity index and measures of adiposity and skeletal muscle                                                                                                                                             7

  Boule et al. \[[@B61]\]                          IVGTT                                                                                                     Pre/postinterventional                     African American                                                173                            32.9 (30.8-35.0) (F)\                                      37/63                        Nondiabetic                               White American                                                423    AIRg and DI higher and Si lower in BA vs WE                                                                                                                                                                                                                             8
                                                                                                                                                                                                                                                                                                       33.1 (30.2-36.0) (M)                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Reimann et al. \[[@B28]\]                        OGTT                                                                                                      Cross-sectional                            Black South African (with and without abdominal obesity)        86                             27 (23, 30) (without abdominal obesity)\                   0/100                        Nondiabetic                               White South African (with and without abdominal obesity)      90     No ethnic difference in age, BMI, or insulin resistance by HOMA-IR. 2 h C-peptide post glucose significantly higher in BA vs. WE in the group with abdominal obesity. No ethnic difference in post glucose C-peptide in the lean group                                  7
                                                                                                                                                                                                                                                                                                       32 (28, 35) (with abdominal obesity)                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Elbein et al. \[[@B44]\]                         OGTT\                                                                                                     Case control                               African American                                                159                            38.4 ± 9.2                                                 34/66                        NGT and IGT                               European American                                             344    OGTT: area under curve insulin and insulinogenic index higher in BA. AIRg and DI higher in BA, no significant difference in Si                                                                                                                                          9
                                                   Insulin- or tolbutamide-modified IVGTT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Herman et al. \[[@B35]\]                         OGTT                                                                                                      RCT (data obtained before randomisation)   African American                                                752                            50.5 ± 10.1                                                26/74                        IGT                                       White American                                                2117   Higher CIR in BA in the context of greater insulin resistance in BA by HOMA IR and higher BMI                                                                                                                                                                           7

  Rasouli et al. \[[@B60]\]                        OGTT\                                                                                                     Cross-sectional                            African American (obese, with and without family hx of T2D)     121                            38 (36-39)                                                 41/59                        NGT                                       White American (obese, with and without family hx of T2D)     212    No difference in 2 h OGTT insulin or insulin area under the curve, but higher AIRg in BA. No difference in AIRmax, lower DI max. BA had lower Si but higher disposition index.\                                                                                         9
                                                   IVGTT\                                                                                                                                                                                                                                                                                                                                                                                                                                                     No difference in age, BMI, or WHR between ethnic groups                                                                                                                                                                                                                 
                                                   Arginine stimulation test in subgroup                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Goedecke et al. \[[@B27]\]                       OGTT\                                                                                                     Cross-sectional                            Native black South African (lean and obese)                     29                             24 ± 2 (lean) and 28 ± 1 (obese)                           0/100                        NGT                                       White South African (lean and obese)                          28     Higher insulinogenic index 30 mins in BA, but no difference when adjusted for insulin sensitivity. Higher AIR and lower Si in BA, adjusted for visceral and subcut adipose volume. No ethnic difference in DI. No ethnic difference in BMI, WHR, or body fat % by DXA   9
                                                   Insulin-modified IVGTT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Willig et al. \[[@B51]\]                         Insulin- or tolbutamide-modified IVGTT                                                                    Cross-sectional                            African American                                                87                             35.3 ± 4.5                                                 0/100                        Nondiabetic                               European American                                             68     AIRg higher and Si lower in BA. No ethnic difference in age and BMI                                                                                                                                                                                                     8

  Chandler-Laney et al. \[[@B52]\]                 Insulin-modified IVGTT                                                                                    Cross-sectional                            African American                                                43                             25.9 ± 3.4 (premenopausal), 55.7 ± 4.2 (postmenopausal)    0/100                        NGT                                       European American                                             63     Higher X0 (acute C-peptide secretion), Phi1 and Phi(tot) in BA after adjusting for age. Lower Si in BA, after adjusting for body fat % by DXA                                                                                                                           9

  Goree et al. \[[@B53]\]                          Insulin-modified IVGTT                                                                                    Cross-sectional                            African American                                                42                             Premenopausal 24.8 ± 3.3\                                  0/100                        NGT                                       European American                                             64     AIRg and DI higher in BA. AIR remained higher after adjusting for Si.                                                                                                                                                                                                   9
                                                                                                                                                                                                                                                                                                       Postmenopausal 56.6 ± 5.1                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Chow et al. \[[@B54]\]                           Insulin-modified IVGTT                                                                                    Cross-sectional                            African American                                                17                             36 ± 9                                                     0/100                        Nondiabetic                               White American                                                17     AIRg and DI higher in BA, Si lower. Matched for age and BMI. Lower WHC and higher body fat % in BA                                                                                                                                                                      7

  Ladson et al. \[[@B55]\]                         OGTT                                                                                                      Case control                               African American with PCOS                                      36                             27.9 ± 5.0                                                 0/100                        Nondiabetic                               White American with PCOS                                      63     Higher fasting insulin and insulinogenic index (30 mins) in BA. Similar BMI and WHR in both ethnic groups                                                                                                                                                               6

  Szczepaniak et al. \[[@B45]\]                    Insulin-modified IVGTT                                                                                    Cross-sectional                            African American                                                20                             37 ± 3                                                     35/65                        NGT and IGT                               Non-Hispanic white                                            30     Higher AIRg and DI in BA, lower Si. Ethnic groups matched for age, sex, BMI, and BP. Adjusted for HbA1c                                                                                                                                                                 8

  Goff et al. \[[@B33]\]                           IVGTT                                                                                                     Cross-sectional                            UK Afro-Caribbean                                               35                             42.6 ± 7 (F)\                                              29/71                        Nondiabetic                               UK white                                                      417    When adjusted for age and BMI: higher AIRg and lower Si in BA. No ethnic difference in DI                                                                                                                                                                               7
                                                                                                                                                                                                                                                                                                       44.9 ± 9.7 (M)                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Ebenibo et al. \[[@B62]\]                        IVGTT                                                                                                     Prospective cohort                         African American                                                142                            40.2 ± 10.7 (HbA1c \< 5.7%), 46.5 ± 8.9 (HbA1c 5.7-6.4%)   25/75                        NGT                                       White American                                                138    Within each HbA1c group, BA had higher AIRg and DI. Similar insulin sensitivity between ethnic groups by hyperinsulinaemic-euglycaemic clamp                                                                                                                            9

  Ferguson et al. \[[@B58]\]                       HOMA%B\                                                                                                   Pre/postinterventional                     African American                                                42                             26 (median), 9 (IQR) (F)\                                  45/55                        Nondiabetic                               European American                                             106    Higher HOMA%B in BA\                                                                                                                                                                                                                                                    8
                                                   Insulin-modified IVGTT                                                                                                                                                                                                                              27 (median), 18 (IQR) (M)                                                                                                                                                                              Lower Si and higher AIR and DI in BA, adjusted for age, sex, and BMI                                                                                                                                                                                                    

  Healy et al. \[[@B36]\]                          HOMA%B\                                                                                                   Cross-sectional                            African American (obese)                                        84                             46.4 ± 10.2                                                7/93                         Prediabetic (IFG and IGT)                 White American (obese)                                        61     HOMA%B lower in BA\                                                                                                                                                                                                                                                     9
                                                   OGTT\                                                                                                                                                                                                                                                                                                                                                                                                                                                      OGTT fasting and post glucose C-peptide levels lower in BA, no difference in insulinogenic index\                                                                                                                                                                       
                                                   Insulin-modified IVGTT                                                                                                                                                                                                                                                                                                                                                                                                                                     Higher AIRg in BA (not significant), similar Si, and significantly higher DI in BA. BA had higher BMI and higher body fat % by DXA.                                                                                                                                     

  Goff et al. \[[@B29]\]                           MMTT plus high-fructoseor high-glucose feeding                                                            Cross-sectional                            UK black African                                                9                              38.3 ± 2.0                                                 100/0                        Nondiabetic                               UK white                                                      417    No significant ethnic difference in insulin or C-peptide iAUC post feeding                                                                                                                                                                                              7

  Owei et al. \[[@B46]\]                           IVGTT                                                                                                     Prospective cohort                         African American (with parental T2D)                            184                            43.2 ± 10.0                                                Not reported by ethnicity    NGT and IGT                               European American (with parental T2D)                         151    Higher AIR in BA. Lower insulin sensitivity by hyperinsulinaemic-euglycaemic clamp in blacks. BA younger and higher BMI                                                                                                                                                 8

  Shah et al. \[[@B47]\]                           Hyperglycaemic clamp\                                                                                     Cross-sectional                            African American                                                24                             Not reported by ethnicity                                  Not reported by ethnicity    NGT, IGT, and T2D                         White American                                                74     Higher acute insulin response and DI in BA, late-phase insulin tended to be higher in BA. No ethnic difference in insulin sensitivity index                                                                                                                             8
                                                   Arginine-stimulated insulin response                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Osei et al. \[[@B37]\]                           Fasting parameters to determine HOMA%B\                                                                   Cross-sectional                            Overweight/obese African American                               67                             46.3 ± 10.3                                                0/100                        Prediabetic (IFG and IGT)                 Overweight/obese white American                               28     HOMA%B: no ethnic difference\                                                                                                                                                                                                                                           9
                                                   OGTT\                                                                                                                                                                                                                                                                                                                                                                                                                                                      OGTT: fasting C-peptide and peak C-peptide lower in BA, fasting and mean insulin tended to be higher\                                                                                                                                                                   
                                                   Insulin-modified IVGTT                                                                                                                                                                                                                                                                                                                                                                                                                                     IVGTT: AIR higher in BA, not significant. DI significantly higher in BA. BA had higher BMI and higher percentage body fat by DEXA. Insulin sensitivity by Si same between ethnic groups                                                                                 

  Piccinini et al. \[[@B56]\]                      Insulin-modified IVGTT                                                                                    Cross-sectional                            African American                                                18                             25 ± 4                                                     0/100                        NGT                                       European American                                             29     Insulin secretion rate (ISR) as modelled by C-peptide higher in BA vs. WE                                                                                                                                                                                               8

  Mohandas et al. \[[@B30]\]                       MMTT\                                                                                                     Cross-sectional                            UK black African                                                19                             54.1 ± 7.7                                                 100/0                        T2D (recently diagnosed)                  UK white                                                      15     MMTT: fasting and AUC C-peptide lower in BA, no difference in insulin AUC\                                                                                                                                                                                              9
                                                   Hyperglycaemic clamp                                                                                                                                                                                                                                                                                                                                                                                                                                       HC: second-phase C-peptide lower in BA, no difference in insulin iAUC. Groups matched for age, BMI, HbA1c, and duration of diabetes                                                                                                                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AIR: acute insulin response; BA: black African; BMI: body mass index; CIR: corrected insulin response; DI: disposition index; DXA: dual-energy X-ray absorptiometry; FHx: family history; HIE: hepatic insulin extraction; HOMA%B: homeostatic model assessment of beta cell function; HOMA-IR: homeostatic model assessment of insulin resistance; iAUC: incremental area under the curve; IGT: impaired glucose tolerance; IVGTT: intravenous glucose tolerance test; mNOS: modified Newcastle-Ottawa scale; MMTT: mixed meal tolerance test; NGT: normal glucose tolerance; OGTT: oral glucose tolerance test (refers to 2-hour post 75 g oral glucose); PCOS: polycystic ovarian syndrome; RCT: randomised controlled trial; Si: insulin sensitivity index; T2D: type 2 diabetes; WBISI: whole-body insulin sensitivity index; WE: white European; WHR: waist-hip ratio.

###### 

Ethnic comparison of insulin responses.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                              Insulin response by ethnicity                                                                                   
  ------------------------------------------- ------------------------------------------ -------------------------------------------------------------------- ----------------------
  Models based on fasting measures (HOMA%B)   \[[@B41]\] (NGT and IFG)\                  \[[@B37]\] (IFG/IGT)                                                 \[[@B32]\] (T2D)\
                                              \[[@B58]\]                                                                                                      \[[@B36]\] (IFG/IGT)

                                                                                                                                                              

  *Cumulativen(fasting)*                      **2253**                                   **95**                                                               **4709**

                                                                                                                                                              

  Oral nutrient stimulation                   \[[@B34]\]\                                \[[@B26]\] (BA \> WE at 30 mins, but no difference in total iAUC)\   \[[@B24]\]\
                                              \[[@B50]\]\                                \[[@B31]\]\                                                          \[[@B25]\]
                                              \[[@B48]\]\                                \[[@B40]\] (IGT and T2D)\                                            
                                              \[[@B40]\] (NGT)\                          \[[@B59]\]\                                                          
                                              \[[@B42]\]\                                \[[@B60]\]\                                                          
                                              \[[@B35]\]\                                \[[@B27]\]\                                                          
                                              \[[@B55]\]\                                \[[@B36]\] (IFG/IGT)\                                                
                                              \[[@B44]\] (NGT and IGT)\                  \[[@B37]\] (IFG/IGT)\                                                
                                              \[[@B28]\] (in obese only)                 \[[@B38]\] (T2D)\                                                    
                                                                                         \[[@B30]\] (T2D)\                                                    
                                                                                         \[[@B28]\] (in lean only)\                                           
                                                                                         \[[@B29]\]                                                           

                                                                                                                                                              

  *Cumulativen(oral)*                         **4541**                                   **2068**                                                             **33**

                                                                                                                                                              

  IV glucose stimulation                      \[[@B63]\]\                                \[[@B30]\] (T2D)                                                     \[[@B25]\]
                                              \[[@B39]\] (NGT and IGT)\                                                                                       
                                              \[[@B64]\] (second-phase response only)\                                                                        
                                              \[[@B65]\]\                                                                                                     
                                              \[[@B49]\]\                                                                                                     
                                              \[[@B59]\]\                                                                                                     
                                              \[[@B43]\] (NGT and IGT)\                                                                                       
                                              \[[@B60]\]\                                                                                                     
                                              \[[@B27]\]\                                                                                                     
                                              \[[@B54]\]\                                                                                                     
                                              \[[@B33]\]\                                                                                                     
                                              \[[@B58]\]\                                                                                                     
                                              \[[@B46]\] (NGT and IGT)\                                                                                       
                                              \[[@B45]\] (NGT and IGT)\                                                                                       
                                              \[[@B62]\]\                                                                                                     
                                              \[[@B36]\] (IFG/IGT)\                                                                                           
                                              \[[@B47]\] (NGT, IGT, and T2D)\                                                                                 
                                              \[[@B37]\] (IFG/IGT)\                                                                                           
                                              \[[@B38]\] (T2D)\                                                                                               
                                              \[[@B53]\]\                                                                                                     
                                              \[[@B51]\]\                                                                                                     
                                              \[[@B44]\] (NGT and IGT)\                                                                                       
                                              \[[@B61]\]                                                                                                      

                                                                                                                                                              

  *Cumulativen(IV)*                           **4461**                                   **34**                                                               **18**
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NGT and nondiabetic subjects, unless otherwise specified. Cumulative *n* fasting, oral, and IV refer to the total number of participants (BA and WE) in the studies using fasting measures, oral nutrient stimulation, and intravenous glucose stimulation techniques, respectively (note that each study may be presented in more than one category). BA: black African; WE: white European; NGT: normal glucose tolerance; IFG: impaired fasting glucose; IGT: impaired glucose tolerance; T2D: type 2 diabetes.

###### 

Ethnic comparison of insulin secretory function as determined by C-peptide levels.

  ----------------------------------------------------------------------------------------------------------------------------------------
                  Insulin response by ethnicity                                   
  --------------- ------------------------------- ------------------------------- --------------------------------------------------------
  NGT             \[[@B48]\] (OGTT)\              \[[@B34]\] (OGTT)\              \[[@B50]\] (GCT)\
                  \[[@B52]\] (IVGTT)\             \[[@B63]\] (IVGTT)\             \[[@B25]\] (oral glucose, IV tolbutamide and glucagon)
                  \[[@B56]\] (IVGTT)\             \[[@B28]\] (OGTT, lean only)\   
                  \[[@B28]\] (OGTT, obese only)   \[[@B29]\] (MMTT)               

                                                                                  

  "Prediabetic"                                                                   \[[@B36]\] (OGTT)\
                                                                                  \[[@B37]\] (OGTT)

                                                                                  

  T2D                                                                             \[[@B30]\] (MMTT, HC)

                                                                                  

  Mixed                                           \[[@B31]\] (OGTT)\              
                                                  \[[@B42]\] (OGTT)               

                                                                                  

  *Cumulativen*   **262**                         **1005**                        **753**
  ----------------------------------------------------------------------------------------------------------------------------------------

Cumulative *n* refers to the total number of participants (BA and WE) in the studies. BA: black African; WE: white European; NGT: normal glucose tolerance; T2D: type 2 diabetes; IVGTT: intravenous glucose tolerance test; OGTT: oral glucose tolerance test; GCT: glucose challenge test; MMTT: mixed meal tolerance test; HC: hyperglycaemic clamp.
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